Comparison of Methods for Testing Mismatch Repair Status in Endometrial Cancer

• Published in: International journal of molecular sciences Vol. 24; no. 19; p. 14468
• Main Authors: Mendiola, Marta, Heredia-Soto, Victoria, Ruz-Caracuel, Ignacio, Baillo, Amparo, Ramon-Patino, Jorge Luis, Escudero, Francisco Javier, Miguel, Maria, Pelaez-Garcia, Alberto, Hernandez, Alicia, Feliu, Jaime, Hardisson, David, Redondo, Andres
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 01.10.2023; MDPI
• Subjects: DNA methylation; Endometrial cancer; endometrial carcinoma; Genes; methylation; microsatellite instability; mismatch repair deficiency; Mutation; Oncology; Protein expression; Proteins
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms241914468

Approximately 20–30% of endometrial carcinomas (EC) are characterized by mismatch repair (MMR) deficiency (dMMR) or microsatellite instability (MSI), and their testing has become part of the routine diagnosis. The aim of this study was to establish and compare the MMR status using various approaches. Immunohistochemistry (IHC), PCR-based MSI, and the detection of defects in the four key MMR genes (MLH1, PMS2, MSH2, and MSH6) via methylation-specific multiplex ligation-dependent probe amplification (MLPA) and targeted next-generation sequencing (NGS) were performed. MSH3 expression was also evaluated. A set of 126 early-stage EC samples were analyzed, 53.2% of which were dMMR and 46.8% of which were proficient MMR (pMMR) as determined using IHC, whereas 69.3% were classified as microsatellite stable, while 8.8% and 21.9% were classified MSI-low (MSI-L) and MSI-high (MSI-H), respectively. In total, 44.3% of the samples showed genetic or epigenetic alterations in one or more genes; MLH1 promoter methylation was the most common event. Although acceptable concordance was observed, there were overall discrepancies between the three testing approaches, mainly associated with the dMMR group. IHC had a better correlation with MMR genomic status than the MSI status determined using PCR. Further studies are needed to establish solid conclusions regarding the best MMR assessment technique for EC.